Video education about side effects of chemotherapy and immunotherapy and its impact on the anxiety, depression, and distress level of cancer patients

• Published in: BMC Psychology Vol. 10; no. 1; p. 278
• Main Authors: Baralo, Bohdan, Paravathaneni, Mahati, Jain, Akhil, Buragamadagu, Bhanusowmya, Khanam, Aliza, Iqbal, Sabah, Hossain, Samia, Mulla, Sana, Choi, Eugene, Thirumaran, Rajesh
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 24.11.2022; BioMed Central; BMC
• Subjects: Anxiety; Anxiety - diagnosis; Anxiety Disorders; Cancer; Cancer education; Cancer patients; Cancer therapies; Chemotherapy; Comparative analysis; Complications and side effects; Confidence intervals; Consent; Demographic aspects; Depression; Depression - diagnosis; Depression, Mental; Drug therapy; Education; Enrollments; Equipment and supplies; Health aspects; Humans; Immunotherapy; Medical research; Medicine, Experimental; Mental depression; Neoplasms - drug therapy; Patient education; Psychological aspects; Psychological distress; Questionnaires; Risk factors; Side effects; Statistical analysis; Stress (Psychology); Teaching; Video tapes in education; United States; Depression; Anxiety; Psychological distress; Cancer education
• ISSN: 2050-7283; 2050-7283
• DOI: 10.1186/s40359-022-00994-3

Patients diagnosed with cancer are at higher risk of anxiety, depression, and overall distress. These mood disturbances are risk factors for non-adherence to cancer treatment, increased length of stay during hospital admissions, increased number of visits to the emergency department, and also impact survival. Although paper handouts about the potential side effects are widely used in the oncology practice studies have shown that digital educational material is known to work better when compared to traditional methods. However, the impact of video education on anxiety, depression, and distress have not been previously evaluated. Our study aimed to assess whether video education about potential chemotherapy and immunotherapy can reduce anxiety, depression, and distress levels. After IRB approval, we enrolled patients who were fluent in English, younger than 80 years of age, and who were able to provide informed consent. The Hospital Anxiety and Depression Scale and Distress Thermometer were used to assess distress, as well as depression and anxiety before and after watching video educational material. Paired t-test was used to compare the differences between the scores before and after watching educational videos. The statistical software GraphPad Prism 9, San Diego, California, was used to perform the statistical analysis. We enrolled 29 patients, of whom 20 completed the study, six withdrew, two were lost to follow-up, and one did not complete the initial questionnaire. Of all patients that completed the study 85% of the patient found videos helpful, and they were 7/10 likely to recommend them to other patients who may experience symptoms. The mean depression score changed from 4.75 before to 4.9 after watching the videos (p 0.77), distress score from 2.3 to 2.65 (p 0.52), and anxiety scores changed from 4.85 to 6.15 (p 0.03). The feedback provided by the patients indicated that they were more willing to watch the videos related to the side effects they experienced at their free time and convenience. Our study suggests that patients were open to video education and found it helpful and worth watching. However, the exposure of the patients to the videos about potential side effects of cancer treatment, including those patients do not experience, may lead to increased anxiety.